AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ONCOSIL MEDICAL LTD

1.015

+0.0353.57%

Volume:16.43K

Turnover:16.34K

Market Cap:37.25M

PE:-2.12

High:1.015

Open:0.980

Low:0.980

Close:0.980

52wk High:2.090

52wk Low:0.370

Shares:36.70M

Float Shares:27.77M

Volume Ratio:0.04

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.479

EPS(LYR):-0.479

ROE:-268.15%

ROA:-78.85%

PB:7.46

PE(LYR):-2.12

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.18%

Capital Flow

Inflow:

Outflow:

News

Australia's OncoSil Medical Gains Most in over 2 Months on Reaching 100-Th Patient Milestone

Oncosil Medical - Completes A$4.0 Mln Placement at an Issue Price of A$1.00 Per Share

THOMSON REUTERS

Oncosil Medical - Funds to Support Commercial Launch of Oncosil Device in US and Australia

THOMSON REUTERS

Oncosil Medical - Receives A$5.6 Mln Commitments from Major Institutional Investors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/OSL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"OSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":1.015,"timestamp":1789452720000,"preClose":0.98,"halted":0,"volume":16425,"delay":0,"changeRate":0.035714285714285636,"nameEN":"ONCOSIL MEDICAL LTD","floatShares":27770751,"shares":36703600,"eps":-0.479499,"marketStatus":"Not Yet Opened","change":0.035,"latestTime":"09-15 16:12:00 AEST","open":0.98,"high":1.015,"low":0.98,"amount":16342,"amplitude":0.035714,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.479499,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.98,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.03778502677385713,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSL.AU","preClose":0.98,"auctionPrice":0.98,"auctionVolume":25,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452480805}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","floatShares":27770751,"roa":"-78.85%","roe":"-268.15%","lyrEps":-0.4795,"volumeRatio":0.03778502677385713,"shares":36703600,"dividePrice":0,"high":1.015,"amplitude":0.035714,"preClose":0.98,"low":0.98,"week52Low":0.37,"pbRate":"7.46","psRate":"7.32","week52High":2.09,"institutionHeld":0,"latestPrice":1.015,"eps":-0.479499,"divideRate":0,"volume":16425,"delay":0,"ttmEps":-0.479499,"open":0.98,"prevYearClose":0.97,"prevWeekClose":0.975,"prevMonthClose":1.15,"prevQuarterClose":0.71,"fiveDayClose":1.065,"twentyDayClose":1.15,"sixtyDayClose":0.59,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-03","symbol":"OSL.AU","defaultRemindTime":1748908800000,"type":"split","dateTimestamp":1748872800000,"forFactor":400,"toFactor":1,"ratio":400},{"market":"AU","date":"2022-05-05","symbol":"OSL.AU","defaultRemindTime":1651708800000,"type":"split","dateTimestamp":1651672800000,"forFactor":987878,"toFactor":1000000,"ratio":0.987878}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665349558","title":"Australia's OncoSil Medical Gains Most in over 2 Months on Reaching 100-Th Patient Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349558","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665349558?lang=en_us&edition=fundamental","pubTime":"2026-09-08 10:29","pubTimestamp":1788834581,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone** Shares of Australia's OncoSil MedicalOSL.AXrise as much as 19.2% at A$1.120, on track for their bigg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N45005J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392176","title":"Oncosil Medical - Completes A$4.0 Mln Placement at an Issue Price of A$1.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392176?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:12","pubTimestamp":1788765127,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0YS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392143","title":"Oncosil Medical - Funds to Support Commercial Launch of Oncosil Device in US and Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:12","pubTimestamp":1788765127,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0YS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392114","title":"Oncosil Medical - Receives A$5.6 Mln Commitments from Major Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392114?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:12","pubTimestamp":1788765127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OSL.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.011805}]}}